p-methoxy-n-methylphenethylamine has been researched along with rolipram in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alfonso, A; Botana, LM; Botana, MA; Cabado, AG; Louzao, MC; Vieytes, MR | 1 |
Barreto, EO; Carvalho, VF; Cordeiro, RS; E Silva, PM; Lagente, V; Lugnier, C; Martins, MA | 1 |
2 other study(ies) available for p-methoxy-n-methylphenethylamine and rolipram
Article | Year |
---|---|
Influence of protein kinase C, cAMP and phosphatase activity on histamine release produced by compound 48/80 and sodium fluoride on rat mast cells.
Topics: Animals; Colforsin; Cyclic AMP; Enzyme Activation; Ethers, Cyclic; Histamine Release; In Vitro Techniques; Mast Cells; Okadaic Acid; p-Methoxy-N-methylphenethylamine; Phosphodiesterase Inhibitors; Phosphoprotein Phosphatases; Protein Kinase C; Protein Kinases; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Rolipram; Sodium Fluoride; Tetradecanoylphorbol Acetate | 1992 |
Increased levels of cyclic adenosine monophosphate contribute to the hyporesponsiveness of mast cells in alloxan diabetes.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Antigens; Bradykinin; Bucladesine; Cell Degranulation; Cell Separation; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Diabetes Mellitus, Experimental; Dinitrophenols; Dose-Response Relationship, Drug; Immunoglobulin E; Male; Mast Cells; p-Methoxy-N-methylphenethylamine; Phosphodiesterase Inhibitors; Pleura; Rats; Rolipram; Stimulation, Chemical | 2004 |